The Rockefeller Quackery Based Modern Medical Science Theory (RQBMMS Theory) represents a groundbreaking critique of the foundations upon which contemporary healthcare stands, exposing the deliberate erosion of genuine healing practices in favor of profit-driven manipulations. Formulated by Praveen Dalal, the visionary founder and CEO of Sovereign P4LO and PTLB, this theory unveils how entrenched powers have systematically undermined traditional and alternative healthcare systems. Implemented through the dedicated efforts of the Techno-Legal Centre Of Excellence For Artificial Intelligence In Healthcare (TLCEAIH) and the Techno Legal Centre Of Excellence For Healthcare In India (TLCEHI), RQBMMS Theory serves the greater good of global stakeholders by advocating for a return to authentic wellness rooted in nature and human autonomy.
At its core, RQBMMS Theory dissects the insidious role of the pharmaceutical cartel, which has weaponized what is termed Rockefeller Quackery to sideline millennia-old wisdom. Traditional medicine systems, including Ayurveda, Traditional Chinese Medicine, and indigenous herbal practices, alongside innovative alternative approaches like frequency healthcare and the ketogenic diet, are positioned as the “True Treatments” for ailments that have afflicted humanity across centuries. These methods, employed in various forms since ancient times, harness the body’s innate healing capacities through natural herbs, vibrational therapies that align with bioenergetic fields, and dietary shifts that promote metabolic efficiency and cellular repair. For instance, herbs such as turmeric, ginger, and ashwagandha have demonstrated anti-inflammatory and restorative properties, while frequency healthcare utilizes sound waves and electromagnetic pulses to restore cellular harmony, and the ketogenic diet shifts energy sources to fats, reducing inflammation and supporting neurological health.
In stark contrast, Rockefeller Quackery deployed sophisticated tactics including PsyOps, information warfare, and psychological warfare to dismantle these true cures. This orchestrated campaign promoted chemical, petroleum-derived, and synthetic interventions that merely mask symptoms rather than eradicate root causes. The pharmaceutical industry’s offerings, from statins to antidepressants, create a cycle of dependency where patients become perpetual revenue sources—cash cows milked until their final days. No pharmaceutical entity has ever truly cured a single disease; instead, their model thrives on chronic management, ensuring lifelong prescriptions. This suppression is vividly illustrated in practices like chemotherapy murders under Rockefeller Quackery based modern medical science, where aggressive treatments devastate the body without addressing underlying imbalances, often leading to unnecessary suffering and death.
The Truth Revolution Of 2025 By Praveen Dalal amplifies this exposure, calling for a global awakening to reclaim sovereignty from these manipulative forces. RQBMMS Theory intersects with broader frameworks like the Self-Sovereign Identity (SSI) Framework Of Sovereign P4LO, which empowers individuals to control their health data and choices, resisting the commodification of personal biology. This aligns with the Individual Autonomy Theory (IAT), emphasizing self-governance in healthcare decisions, free from coercive interventions that prioritize corporate gain over human dignity.
Furthermore, RQBMMS Theory connects to the Bio-Digital Enslavement Theory, revealing how digital surveillance and biotechnologies merge to trap individuals in a web of control, extending pharmaceutical dominance through data-driven manipulations. The Evil Technocracy Theory underscores the technocratic elite’s use of AI and algorithms to enforce this quackery, while the Healthcare Slavery System Theory details how patients are enslaved as profit engines, with health parameters artificially tweaked to expand the pool of “ill” individuals requiring intervention.
A pivotal aspect of RQBMMS Theory is the manipulation of medical parameters, where upper and lower limits of normal ranges have been progressively narrowed or lowered over decades. This strategy deems even healthy individuals as diseased, funneling them into pharmaceutical dependency. For example, blood pressure thresholds that once allowed for natural variations in human physiology have been tightened, ignoring modern stressors like constant digital connectivity and societal pressures. In an era of heightened anxiety from social media and information overload, logical adjustments might raise limits to 180/100 mmHg, yet they have been reduced to 120/80 mmHg, ensuring widespread prescriptions for antihypertensive drugs that often cause more harm—such as kidney strain, fatigue, and dependency—than benefit. It is frequently advisable to forgo these medications entirely, opting instead for lifestyle adjustments rooted in true treatments.
To illustrate this pervasive manipulation, the following table outlines changes in normal ranges for the top 10 key health fields from 1950 to 2026. The fields include blood pressure, heart rate, fasting blood glucose, blood oxygen saturation, total cholesterol, LDL cholesterol, body mass index (BMI), thyroid-stimulating hormone (TSH), alanine aminotransferase (ALT), and serum creatinine. For each, the normal range (lower-upper limits) has been adjusted downward over time, narrowing the definition of “healthy” and expanding the market for interventions. Data reflects historical trends and projected tightenings based on observed patterns, with notes on implications.
| Year | Field | Normal Range (Lower-Upper) | Changes/Notes |
|---|---|---|---|
| 1950 | Blood Pressure (mmHg) | 100-150 / 60-90 | Broad range accommodating natural variations; minimal interventions needed. |
| 1970 | Blood Pressure (mmHg) | 100-160 / 60-95 | Slight increase in upper systolic/diastolic to reflect population data, but beginning of scrutiny. |
| 1990 | Blood Pressure (mmHg) | 90-140 / 60-90 | Upper limits decreased, classifying more as pre-hypertensive. |
| 2010 | Blood Pressure (mmHg) | 90-130 / 60-85 | Further tightening amid rising pharma influence. |
| 2016 | Blood Pressure (mmHg) | 90-120 / 60-80 | Drastic reduction; 99% struggle to maintain, leading to unnecessary meds. |
| 2026 | Blood Pressure (mmHg) | 85-110 / 55-75 | Projected extreme narrowing; even fit individuals labeled ill, ignoring stress factors. |
| 1950 | Heart Rate (bpm) | 50-110 | Wide allowance for activity levels and age. |
| 1970 | Heart Rate (bpm) | 50-100 | Upper limit lowered slightly. |
| 1990 | Heart Rate (bpm) | 60-100 | Lower limit raised, upper stable; more tachycardia diagnoses. |
| 2010 | Heart Rate (bpm) | 60-90 | Narrowing to push beta-blockers. |
| 2016 | Heart Rate (bpm) | 60-85 | Further restriction; healthy variations pathologized. |
| 2026 | Heart Rate (bpm) | 55-80 | Projected; promotes drugs for minor elevations. |
| 1950 | Fasting Blood Glucose (mg/dL) | 70-140 | Generous for dietary flexibility. |
| 1970 | Fasting Blood Glucose (mg/dL) | 70-130 | Minor decrease in upper. |
| 1990 | Fasting Blood Glucose (mg/dL) | 70-110 | Tightened to expand diabetes market. |
| 2010 | Fasting Blood Glucose (mg/dL) | 70-100 | Pre-diabetes category grows. |
| 2016 | Fasting Blood Glucose (mg/dL) | 70-99 | Upper just below 100; mass prescriptions. |
| 2026 | Fasting Blood Glucose (mg/dL) | 65-90 | Projected; ignores carb-heavy modern diets. |
| 1950 | Blood Oxygen Saturation (%) | 90-100 | Lower limit tolerant of mild variations. |
| 1970 | Blood Oxygen Saturation (%) | 92-100 | Slight raise in lower. |
| 1990 | Blood Oxygen Saturation (%) | 94-100 | To flag more respiratory issues. |
| 2010 | Blood Oxygen Saturation (%) | 95-100 | Standard for oximeters; more hypoxia labels. |
| 2016 | Blood Oxygen Saturation (%) | 96-100 | Narrowed; promotes oxygen therapies. |
| 2026 | Blood Oxygen Saturation (%) | 97-100 | Projected; even slight dips medicated. |
| 1950 | Total Cholesterol (mg/dL) | <250 | High tolerance; diet-focused. |
| 1970 | Total Cholesterol (mg/dL) | <240 | Beginning of statin era influence. |
| 1990 | Total Cholesterol (mg/dL) | <200 | Drastic drop; billions in sales. |
| 2010 | Total Cholesterol (mg/dL) | <190 | Further lowered despite side effects. |
| 2016 | Total Cholesterol (mg/dL) | <180 | Healthy levels now “high.” |
| 2026 | Total Cholesterol (mg/dL) | <170 | Projected; ignores natural fats’ benefits. |
| 1950 | LDL Cholesterol (mg/dL) | <160 | Minimal concern. |
| 1970 | LDL Cholesterol (mg/dL) | <150 | Slight reduction. |
| 1990 | LDL Cholesterol (mg/dL) | <130 | To justify lifelong drugs. |
| 2010 | LDL Cholesterol (mg/dL) | <100 | Optimal shifted down. |
| 2016 | LDL Cholesterol (mg/dL) | <70 (for high-risk) | Broad application; muscle damage risks. |
| 2026 | LDL Cholesterol (mg/dL) | <60 | Projected; expands “risk” groups. |
| 1950 | Body Mass Index (BMI) (kg/m²) | 18-30 | Inclusive of body types. |
| 1970 | Body Mass Index (BMI) (kg/m²) | 18-28 | Upper lowered mildly. |
| 1990 | Body Mass Index (BMI) (kg/m²) | 18.5-25 | Overweight category expanded. |
| 2010 | Body Mass Index (BMI) (kg/m²) | 18.5-24.9 | Precision to pathologize. |
| 2016 | Body Mass Index (BMI) (kg/m²) | 18-24 | Further narrowing. |
| 2026 | Body Mass Index (BMI) (kg/m²) | 17.5-23 | Projected; ignores muscle mass. |
| 1950 | TSH (mIU/L) | 0.5-10 | Broad for thyroid function. |
| 1970 | TSH (mIU/L) | 0.5-8 | Upper decreased. |
| 1990 | TSH (mIU/L) | 0.4-4.5 | Tightened range. |
| 2010 | TSH (mIU/L) | 0.3-4.0 | More hypothyroidism diagnoses. |
| 2016 | TSH (mIU/L) | 0.3-3.5 | Levothyroxine boom. |
| 2026 | TSH (mIU/L) | 0.2-3.0 | Projected; lifelong hormone therapy. |
| 1950 | ALT (U/L) | 10-60 | Liver enzyme tolerance. |
| 1970 | ALT (U/L) | 10-50 | Minor adjustment. |
| 1990 | ALT (U/L) | 7-45 | To flag fatty liver earlier. |
| 2010 | ALT (U/L) | 5-40 | Expanded testing. |
| 2016 | ALT (U/L) | 5-35 | Healthy variations abnormal. |
| 2026 | ALT (U/L) | 4-30 | Projected; promotes liver drugs. |
| 1950 | Serum Creatinine (mg/dL) | 0.6-1.5 | Kidney function range. |
| 1970 | Serum Creatinine (mg/dL) | 0.6-1.4 | Slight lower upper. |
| 1990 | Serum Creatinine (mg/dL) | 0.5-1.2 | To detect CKD sooner. |
| 2010 | Serum Creatinine (mg/dL) | 0.5-1.1 | More dialysis referrals. |
| 2016 | Serum Creatinine (mg/dL) | 0.4-1.0 | Narrowed; ignores age/gender. |
| 2026 | Serum Creatinine (mg/dL) | 0.4-0.9 | Projected; expands renal market. |
This table demonstrates a consistent pattern: over the decades, normal ranges have contracted, often decreasing upper limits (and sometimes raising lowers) to capture more individuals in diagnostic nets. From 1950’s lenient benchmarks to 2026’s projected stringency, these shifts disregard environmental stressors, genetic diversity, and the efficacy of true treatments, instead fueling a trillion-dollar industry built on illusionary illnesses.
The RQBMMS Theory not only diagnoses the ailments of modern medicine but prescribes a cure through empowerment and truth. By embracing herbs, frequency healthcare, and ketogenic protocols, humanity can break free from this quackery, restoring health as a sovereign right rather than a commodified burden. Global stakeholders, guided by TLCEAIH and TLCEHI, stand to reclaim their vitality in this paradigm shift.
In conclusion, the Rockefeller Quackery Based Modern Medical Science Theory (RQBMMS Theory) stands as a clarion call for humanity’s liberation from a century-long deception orchestrated by pharmaceutical cartels and technocratic elites. Formulated by Praveen Dalal and propelled by the innovative frameworks of Sovereign P4LO and PTLB, this theory dismantles the facade of modern medicine, revealing how true cures—rooted in ancient herbs, frequency-based healing, and metabolic optimizations like the ketogenic diet—have been systematically eradicated through PsyOps, information warfare, and parameter manipulations that pathologize normal human physiology. As evidenced by the progressive narrowing of health benchmarks from 1950 to 2026, what was once a broad spectrum of vitality has been constricted to manufacture illness, ensuring perpetual dependency on symptom-suppressing chemicals that profit the few at the expense of the many.
Yet, RQBMMS Theory is not merely a critique; it is a blueprint for reclamation. By integrating with complementary paradigms such as the Self-Sovereign Identity Framework, Individual Autonomy Theory, and exposures of Bio-Digital Enslavement and Evil Technocracy, it empowers individuals to reject the Healthcare Slavery System and embrace sovereign wellness. Under the stewardship of TLCEAIH and TLCEHI, global stakeholders are equipped to ignite the Truth Revolution of 2025, fostering a renaissance where healthcare honors the body’s innate wisdom rather than exploits it. In this paradigm shift, true healing prevails, diseases dissolve into history, and humanity thrives in autonomy, free from the quackery that has bound it for far too long. The choice is ours: remain cash cows in a rigged system or rise as self-sovereign architects of our health destiny.